Quantcast
 
Annual return of 118.79% - See How  Click here now!


 

Phase Forward to Present at the William Blair Small Cap Growth Stock Conference

Wed. October 01, 2008; Posted: 09:16 AM
Stocks RSS
WALTHAM, Mass., Oct 01, 2008 (BUSINESS WIRE) -- PFWD | Quote | Chart | News | PowerRating -- Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced its chief executive officer and president, Bob Weiler, and chief financial officer, Rodger Weismann, will present at the William Blair Small Cap Growth Stock Conference at the Waldorf-Astoria Hotel in New York City.

The Phase Forward presentation is scheduled for Tuesday, October 7, 2008 at 1:20 p.m. ET. The presentation will be webcast live and will be available by visiting the Investors section of the company's website at www.phaseforward.com. The webcast will be archived on the company's website for 30 days after the conference ends.

About Phase Forward

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture (InForm(TM), phase I clinic automation (LabPas(TM), clinical data management (Clintrial(TM), clinical trials signal detection (CTSD(TM), strategic pharmacovigilance (Empirica Signal(TM) and Signal Management, adverse event reporting (Empirica Trace(TM), applied data standards (WebSDM(TM) and Web-integrated interactive voice response systems (Clarix(TM). In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards. Phase Forward's products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 280 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.

SOURCE: Phase Forward Incorporated

Public Relations CHEN PR, Inc. Barbara Heffner, 781-672-3112 bheffner@chenpr.com or Investor Relations Integrated Corporate Relations Timothy Dolan, 617-956-6727 tdolan@icrinc.com

For full details on Phase Forward Inc. (PFWD) click here. Phase Forward Inc. (PFWD) has Short Term PowerRatings of 6. Details on Phase Forward Inc. (PFWD) Short Term PowerRatings is available at This Link.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Most Popular News
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2008 The Connors Group, Inc.